HG Shire Announces FDA Approval for Type 1 Gaucher Disease

HG Shire Announces FDA Approval of VPRIVTM (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease

Click here to see full press release: Press Release